The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Molecular mechanisms of diabetic kidney disease
Open accessAbstract
Diabetic kidney disease (DKD) is the leading cause of kidney failure worldwide and the single strongest predictor of mortality in patients with diabetes. DKD is a prototypical disease of gene and environmental interactions. Tight glucose control significantly decreases DKD incidence, indicating that hyperglycemia-induced metabolic alterations, including changes in energy utilization and mitochondrial dysfunction, play critical roles in disease initiation. Blood pressure control, especially with medications that inhibit the angiotensin system, is the only effective way to slow disease progression. While DKD is considered a microvascular complication of diabetes, growing evidence indicates that podocyte loss and epithelial dysfunction play important roles. Inflammation, cell hypertrophy, and dedifferentiation by the activation of classic pathways of regeneration further contribute to disease progression. Concerted clinical and basic research efforts will be needed to understand DKD pathogenesis and to identify novel drug targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493 · cited 1×
“Efforts to define glomerular capillary hypertension in rats and maneuvers to mitigate these hemodynamic perturbations (12) culminated in the demonstration that ACE inhibition and separately angiotensin receptor blockers reduced the progression of clinical DKD (13).”
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Susztak, K., Raff, A. C., Schiffer, M., & Böttinger, E. P. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0894 · Cited by 1,096
Self-citationPodocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Familial Clustering of Diabetic Kidney Disease
Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201801 · Cited by 994
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 974
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Self-citationCellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
DeBerardinis, R. J., & Thompson, C. B. (2012) · Cell · doi:10.1016/j.cell.2012.02.032 · Cited by 858
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
New loci associated with kidney function and chronic kidney disease
Köttgen, A., Pattaro, C., Böger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., et al. (2010) · Nature Genetics · doi:10.1038/ng.568 · Cited by 804
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Glomerular hemodynamics in experimental diabetes mellitus
Hostetter, T. H., Troy, J. L., & Brenner, B. M. (1981) · Kidney International · doi:10.1038/ki.1981.33 · Cited by 790
Self-citationWharram, B. L., Goyal, M., Wiggins, J. E., Sanden, S. K., Hussain, S., Filipiak, W. E., Saunders, T. L., Dysko, R. C., Kohno, K., Holzman, L. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010055 · Cited by 737
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
Self-citationHost Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Adiponectin regulates albuminuria and podocyte function in mice
Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S. R., Ouedraogo, R., Hough, K., McCue, P., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 612
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Gödel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mór, A., Lindenmeyer, M. T., Rastaldi, M.-P., Hartleben, G., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44774 · Cited by 547 · cited 1×
“Decreased activation of mTORC1 protected against DKD in mouse models (77, 78), but complete deletion of mTOR caused glomerular disease (78).”
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
A two-way street: reciprocal regulation of metabolism and signalling
Wellen, K. E., & Thompson, C. B. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3305 · Cited by 528
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485
Wang, W., Wang, Y., Long, J., Wang, J., Haudek, S. B., Overbeek, P., Chang, B. H. J., Schumacker, P. T., & Danesh, F. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.009 · Cited by 476
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 462
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury
Jeansson, M., Gawlik, A., Anderson, G., Li, C., Kerjaschki, D., Henkelman, M., & Quaggin, S. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46322 · Cited by 457
AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
Dugan, L. L., You, Y.-H., Ali, S. S., Diamond-Stanic, M., Miyamoto, S., DeCleves, A.-E., Andreyev, A., Quach, T., Ly, S., Shekhtman, G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66218 · Cited by 456
Meyer, T. W., Bennett, P. H., & Nelson, R. G. (1999) · Diabetologia · doi:10.1007/s001250051447 · Cited by 445
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
The Notch pathway in podocytes plays a role in the development of glomerular disease
Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., & Susztak, K. (2008) · Nature Medicine · doi:10.1038/nm1731 · Cited by 427
Self-citationModular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Glomerular cell number in normal subjects and in type 1 diabetic patients
Steffes, M. W., Schmidt, D., Mccrery, R., & Basgen, J. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00725.x · Cited by 408
Wnt/β-Catenin Signaling Promotes Podocyte Dysfunction and Albuminuria
Dai, C., Stolz, D. B., Kiss, L. P., Monga, S. P., Holzman, L. B., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009010019 · Cited by 399
Intensive Glycemic Control in the ACCORD and ADVANCE Trials
Dluhy, R. G., & McMahon, G. T. (2008) · New England Journal of Medicine · doi:10.1056/nejme0804182 · Cited by 378
de Boer, I. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.16 · Cited by 351
Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron
Cheng, H.-T., Kim, M., Valerius, M. T., Surendran, K., Schuster-Gossler, K., Gossler, A., McMahon, A. P., & Kopan, R. (2007) · Development · doi:10.1242/dev.02773 · Cited by 351
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
Doublier, S., Salvidio, G., Lupia, E., Ruotsalainen, V., Verzola, D., Deferrari, G., & Camussi, G. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1023 · Cited by 344
The GAIN Collaborative Research Group (2007) · Nature Genetics · doi:10.1038/ng2127 · Cited by 318
Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., et al. (2009) · Diabetes · doi:10.2337/db08-1328 · Cited by 317
Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria
White, K. E., Bilous, R. W., Marshall, S. M., El Nahas, M., Remuzzi, G., Piras, G., De Cosmo, S., Viberti, G., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 315
Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci
Li, Q., Seo, J.-H., Stranger, B., McKenna, A., Pe’er, I., LaFramboise, T., Brown, M., Tyekucheva, S., & Freedman, M. L. (2013) · Cell · doi:10.1016/j.cell.2012.12.034 · Cited by 308
New Susceptibility Loci Associated with Kidney Disease in Type 1 Diabetes
Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V.-P., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002921 · Cited by 278
The association of nephrolithiasis with cystic fibrosis
Gibney, E. M., & Goldfarb, D. S. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00403-7 · Cited by 272
Nathan, D. M., Bayless, M., Cleary, P., Genuth, S., Gubitosi-Klug, R., Lachin, J. M., Lorenzi, G., Zinman, B., & for the DCCT/EDIC Research Group (2013) · Diabetes · doi:10.2337/db13-1093 · Cited by 272
Eid, A. A., Ford, B. M., Block, K., Kasinath, B. S., Gorin, Y., Ghosh-Choudhury, G., Barnes, J. L., & Abboud, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.136796 · Cited by 254
Emerging role of autophagy in kidney function, diseases and aging
Huber, T. B., Edelstein, C. L., Hartleben, B., Inoki, K., Jiang, M., Koya, D., Kume, S., Lieberthal, W., Pallet, N., Quiroga, A., et al. (2012) · Autophagy · doi:10.4161/auto.19821 · Cited by 253
Self-citationReduced Nephron Number in Adult Sheep, Hypertensive as a Result of Prenatal Glucocorticoid Treatment
Wintour, E. M., Moritz, K. M., Johnson, K., Ricardo, S., Samuel, C. S., & Dodic, M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042408 · Cited by 252
Mihalik, S. J., Michaliszyn, S. F., de las Heras, J., Bacha, F., Lee, S., Chace, D. H., DeJesus, V. R., Vockley, J., & Arslanian, S. A. (2012) · Diabetes Care · doi:10.2337/dc11-1577 · Cited by 251
Matsusaka, T., Xin, J., Niwa, S., Kobayashi, K., Akatsuka, A., Hashizume, H., Wang, Q.-C., Pastan, I., Fogo, A. B., & Ichikawa, I. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080720 · Cited by 242
ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling
Gee, H. Y., Saisawat, P., Ashraf, S., Hurd, T. W., Vega-Warner, V., Fang, H., Beck, B. B., Gribouval, O., Zhou, W., Diaz, K. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69134 · Cited by 239
CUBN Is a Gene Locus for Albuminuria
Böger, C. A., Chen, M.-H., Tin, A., Olden, M., Köttgen, A., de Boer, I. H., Fuchsberger, C., O'Seaghdha, C. M., Pattaro, C., Teumer, A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060598 · Cited by 237
Vaidya, V. S., Niewczas, M. A., Ficociello, L. H., Johnson, A. C., Collings, F. B., Warram, J. H., Krolewski, A. S., & Bonventre, J. V. (2011) · Kidney International · doi:10.1038/ki.2010.404 · Cited by 234
Ko, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225 · cited 3×
“Recently, we performed genome-wide cytosine methylation analysis of microdissected human kidney tubule epithelial cells from control and DKD subjects (23, 25).”
Self-citationSmeets, B., Kuppe, C., Sicking, E.-M., Fuss, A., Jirak, P., van Kuppevelt, T. H., Endlich, K., Wetzels, J. F. M., Gröne, H.-J., Floege, J., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090970 · Cited by 224
AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Canaud, G., Bienaimé, F., Viau, A., Treins, C., Baron, W., Nguyen, C., Burtin, M., Berissi, S., Giannakakis, K., Muda, A. O., et al. (2013) · Nature Medicine · doi:10.1038/nm.3313 · Cited by 222
Can We Target Tubular Damage to Prevent Renal Function Decline in Diabetes?
Bonventre, J. V. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.008 · Cited by 219
Susztak, K., Ciccone, E., McCue, P., Sharma, K., & Böttinger, E. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020045 · Cited by 214
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14040 · Cited by 207
Antioxidants in the Treatment of Diabetes
Golbidi, S., Alireza Ebadi, S., & Laher, I. (2011) · Current Diabetes Reviews · doi:10.2174/157339911794940729 · Cited by 197
The role of VEGF-A in glomerular development and function
Eremina, V., & Quaggin, S. E. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200401000-00002 · Cited by 194
Wnt/β-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival
Kato, H., Gruenwald, A., Suh, J. H., Miner, J. H., Barisoni-Thomas, L., Taketo, M. M., Faul, C., Millar, S. E., Holzman, L. B., & Susztak, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223164 · Cited by 183
Self-citationAdiponectin Promotes Functional Recovery after Podocyte Ablation
Rutkowski, J. M., Wang, Z. V., Park, A. S. D., Zhang, J., Zhang, D., Hu, M. C., Moe, O. W., Susztak, K., & Scherer, P. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040414 · Cited by 172
Self-citationGrowth-Dependent Podocyte Failure Causes Glomerulosclerosis
Fukuda, A., Chowdhury, M. A., Venkatareddy, M. P., Wang, S. Q., Nishizono, R., Suzuki, T., Wickman, L. T., Wiggins, J. E., Muchayi, T., Fingar, D., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030271 · Cited by 170
Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury
Blattner, S. M., Hodgin, J. B., Nishio, M., Wylie, S. A., Saha, J., Soofi, A. A., Vining, C., Randolph, A., Herbach, N., Wanke, R., et al. (2013) · Kidney International · doi:10.1038/ki.2013.175 · Cited by 164
SnapShot: Notch Signaling Pathway
Ilagan, M. X. G., & Kopan, R. (2007) · Cell · doi:10.1016/j.cell.2007.03.011 · Cited by 144
Genetics of Kidneys in Diabetes (GoKinD) Study
Mueller, P. W., Rogus, J. J., Cleary, P. A., Zhao, Y., Smiles, A. M., Steffes, M. W., Bucksa, J. M., Gibson, T. B., Cordovado, S. K., Królewski, A. S., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080822 · Cited by 134
Siddiqi, F. S., & Advani, A. (2013) · Diabetes · doi:10.2337/db13-0795 · Cited by 132
Sayyed, S. G., Ryu, M., Kulkarni, O. P., Schmid, H., Lichtnekert, J., Grüner, S., Green, L., Mattei, P., Hartmann, G. R., & Anders, H. (2011) · Kidney International · doi:10.1038/ki.2011.102 · Cited by 126
Lin, C., Wang, F., Hsu, Y.-C., Chen, C., Tseng, M., Saleem, M. A., Chang, P., & Wang, J. (2010) · Diabetes · doi:10.2337/db09-0663 · Cited by 126
USRDS: the United States Renal Data System.
(2003) · PubMed · Cited by 123
Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 Diabetes
Caramori, M. L., Parks, A., & Mauer, M. S. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070739 · Cited by 118
The MIF Receptor CD74 in Diabetic Podocyte Injury
Sánchez-Niño, M. D., Sanz, A. B., Ihalmo, P., Lassila, M., Holthöfer, H., Mezzano, S. A., Aros, C., Groop, P., Saleem, M. A., Mathieson, P. W., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020194 · Cited by 110
Normoalbuminuric Diabetic Kidney Disease in the U.S. Population
Mottl, A. K., Kwon, K. S., Mauer, M. S., Mayer-Davis, E. J., Hogan, S. L., & Kshirsagar, A. V. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.010 · Cited by 101
Understanding the Epigenetic Syntax for the Genetic Alphabet in the Kidney
Suszták, K. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050461 · Cited by 83
Epigenetics in Diabetic Kidney Disease
Reddy, M. A., & Natarajan, R. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060629 · Cited by 83
Si, H., Banga, R. S., Kapitsinou, P. P., Ramaiah, M., Lawrence, J., Kambhampati, G., Gruenwald, A., Böttinger, E. P., Glicklich, D. G., TELLIS, V. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004802 · Cited by 81
Renal progenitors in non-diabetic and diabetic nephropathies
Romagnani, P., & Remuzzi, G. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.002 · Cited by 76
Bertuccio, C. A., Verón, D., Aggarwal, P. K., Holzman, L. B., & Tufró, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241620 · Cited by 72
Forbes, J. M., Ke, B., Nguyen, T. V., Henstridge, D. C., Penfold, S. A., Laskowski, A., Sourris, K. C., Groschner, L. N., Cooper, M. E., Thorburn, D. R., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4719 · Cited by 64
Genomewide Linkage Scan for Diabetic Renal Failure and Albuminuria: The FIND Study
Igo, R. P., Iyengar, S. K., Nicholas, S. B., Goddard, K. A. B., Langefeld, C. D., Hanson, R. L., Duggirala, R., Divers, J., Abboud, H. E., Adler, S. G., et al. (2011) · American Journal of Nephrology · doi:10.1159/000326763 · Cited by 62
Temporal Profile of Diabetic Nephropathy Pathologic Changes
Ponchiardi, C., Mauer, M. S., & Najafian, B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0395-7 · Cited by 57
Fine Tuning Gene Expression: The Epigenome
Mohtat, D., & Suszták, K. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.07.004 · Cited by 51
Fetal environment, epigenetics, and pediatric renal disease
Woroniecki, R. P., Gaikwad, A. B., & Suszták, K. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1714-8 · Cited by 49
Sirt1–Claudin-1 crosstalk regulates renal function
Nihalani, D., & Suszták, K. (2013) · Nature Medicine · doi:10.1038/nm.3386 · Cited by 48
Lee, J. E., Gohda, T., Walker, W. H., SKUPIEN, J. K., Smiles, A. M., Holak, R. R., Jeong, J., McDonnell, K. P., Królewski, A. S., & Niewczas, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058007 · Cited by 43
Epigenomics: The Science of No-Longer-Junk DNA. Why Study it in Chronic Kidney Disease?
Ko, Y.-A., & Suszták, K. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.05.007 · Cited by 34
Garg, P. K., & Holzman, L. B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.030 · Cited by 34
KDOQI in the Era of Global Guidelines
Rocco, M. V., & Berns, J. S. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.08.001 · Cited by 19
Breyer, M. D., Coffman, T. M., Flessner, M. F., Fried, L. F., Harris, R. C., Ketchum, C. J., Kretzler, M., Nelson, R. G., Sedor, J. R., & Suszták, K. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03640413 · Cited by 14
Cited by
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Self-citationMolecular mechanisms and therapeutic targets for diabetic kidney disease
Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.012 · Cited by 668
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Chung, K. W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B. A., Park, J., Pei, L., Baur, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.003 · Cited by 651
Self-citationMitochondrial dysfunction in diabetic kidney disease
Forbes, J. M., & Thorburn, D. R. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.9 · Cited by 634
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
Metadata
- Authors
- Reidy, K., Kang, H. M., Hostetter, T., & Susztak, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-06-02
- Volume
- 124
- Issue
- 6
- Pages
- 2333-2340
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2043873569
- Cited by
- 909
- References
- 103
- FWCI
- 33.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.